Filed Pursuant to Rule 424(b)(5)
Registration No. 333-270605
PROSPECTUS SUPPLEMENT
(To Prospectus dated March 16, 2023)
AMPHENOL CORPORATION
$450,000,000 5.050% Senior Notes due 2027
$450,000,000 5.050% Senior Notes due 2029
$600,000,000 5.250% Senior Notes due 2034
We are offering $450,000,000 aggregate principal amount of our 5.050% Senior Notes due 2027 (the “2027 notes”), $450,000,000 aggregate principal amount of our 5.050% Senior Notes due 2029 (the “2029 notes”) and $600,000,000 aggregate principal amount of our 5.250% Senior Notes due 2034 (the “2034 notes,” together with the 2027 notes and the 2029 notes, the “notes”). We will pay interest on the 2027 notes semi-annually on April 5 and October 5 of each year, beginning on October 5, 2024, we will pay interest on the 2029 notes semi-annually on April 5 and October 5 of each year, beginning on October 5, 2024, and we will pay interest on the 2034 notes semi-annually on April 5 and October 5 of each year, beginning on October 5, 2024.
Each series of the notes will be our unsecured senior obligations and will rank equally in right of payment with all of our other unsecured senior indebtedness outstanding from time to time.
On January 30, 2024, we entered into a definitive stock purchase agreement (the “Stock Purchase Agreement”) with Carlisle Companies Incorporated (“Carlisle”), agreeing to acquire the Carlisle Interconnect Technologies (“CIT”) business of Carlisle, subject to customary post-closing adjustments (the “CIT Acquisition”). We intend to use the net proceeds from this offering, together with a combination of cash on hand and other debt financing, to pay the cash consideration for the CIT Acquisition and the payment of fees and expenses related to the CIT Acquisition and, to the extent that the net proceeds from this offering are not used for such purposes, for general corporate purposes. This offering is not conditioned upon the completion of the CIT Acquisition which, if completed, will occur subsequent to the closing of this offering.
We may redeem some or all of the notes from time to time at the applicable redemption prices described in “Description of the Notes — Optional Redemption” in this prospectus supplement.
In addition, each series of the notes will be subject to a “special mandatory redemption” in the event that (i) the CIT Acquisition is not consummated on or prior to the later of (x) January 30, 2025 (the “Outside Date”) or (y) the date that is five business days after any later date to which the parties to the Stock Purchase Agreement may agree to extend the Outside Date in the Stock Purchase Agreement (the “Special Mandatory Redemption End Date”), or (ii) we notify the trustee under the indenture that we will not pursue consummation of the CIT Acquisition. We refer to each of such events as a “special mandatory redemption event.” If a special mandatory redemption event occurs, we will be required to redeem the outstanding notes of each series, at the “special mandatory redemption price” equal to 101% of the principal amount thereof plus accrued and unpaid interest from the date of initial issuance, or the most recent date to which interest has been paid or provided for, whichever is later, to, but not including, the special mandatory redemption date. See “Description of the Notes — Special Mandatory Redemption.” The proceeds from this notes offering will not be deposited into an escrow account and you will not receive a security interest in such proceeds.
Unless we have previously redeemed the notes, if a Change of Control Repurchase Event (as defined herein) occurs, we will be required to offer to repurchase the notes at a price in cash equal to 101% of the principal amount of the notes, plus any accrued and unpaid interest to, but not including, the date of repurchase as described under “Description of the Notes — Change of Control” in this prospectus supplement.
Investing in the notes involves risks. See “Risk Factors” beginning on page S-14 of this prospectus supplement and on page 5 of the accompanying prospectus and the risk factors included in our periodic reports filed with the Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended, each of which is incorporated by reference herein, for a discussion of certain risks you should consider carefully before investing in the notes. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus supplement or the accompanying prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
| | | Prices to Public(1) | | | Underwriting Discount | | | Proceeds to us (before expenses) | |
| | | Per note | | | Total | | | Per note | | | Total | | | Per note | | | Total | |
2027 notes | | | | | 99.887% | | | | | $ | 449,491,500 | | | | | | 0.400% | | | | | $ | 1,800,000 | | | | | | 99.487% | | | | | $ | 447,691,500 | | |
2029 notes | | | | | 99.900% | | | | | $ | 449,550,000 | | | | | | 0.600% | | | | | $ | 2,700,000 | | | | | | 99.300% | | | | | $ | 446,850,000 | | |
2034 notes | | | | | 99.900% | | | | | $ | 599,400,000 | | | | | | 0.650% | | | | | $ | 3,900,000 | | | | | | 99.250% | | | | | $ | 595,500,000 | | |
Combined Total | | | | | | | | | | $ | 1,498,441,500 | | | | | | | | | | | $ | 8,400,000 | | | | | | | | | | | $ | 1,490,041,500 | | |
(1)
Plus accrued interest, if any, from April 5, 2024, if settlement occurs after that date.
Each series of notes is a new issue of securities with no established trading market. We do not intend to apply for listing of the notes on any securities exchange or for quotation of the notes on any automated dealer quotation system.
The notes will be ready for delivery in book-entry form only through the facilities of The Depository Trust Company for the accounts of its participants, including Euroclear Bank SA/NV, as operator of the Euroclear System, and Clearstream Banking, société anonyme, on or about April 5, 2024, which is the third business day following the date of pricing of the notes (such settlement cycle being referred to as “T+3”). You should be advised that trading of the notes may be affected by the T+3 settlement. See “Underwriting.”
Joint Book-Running Managers
| BofA Securities | | | Citigroup | | | J.P. Morgan | | | TD Securities | |
Co-Managers
| BNP PARIBAS | | | COMMERZBANK | | | Goldman Sachs & Co. LLC | | | ING | | | Loop Capital Markets | | | Siebert Williams Shank | |
| Standard Chartered Bank | | | US Bancorp | |
The date of this prospectus supplement is April 2, 2024.